Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
Fig 4
Time post-ATI of first detectable viral load measurement depending on study participant drug regimen, with or without NNRTIs.
Note the statistically significant delay in viral rebound in participants taking NNRTIs pre-ATI (Wilcoxon rank sum test; p-value<0.01).